Stock Quote
Hospira, Inc. (HSP) (NYSE Arca)
sector: Healthcare .
industry: Medical Equipment, Supplies & Distribution ยท
View HSP on other exchanges
$47.55
4:01pm EST
+1.43%
$46.88
$47.06
562,761
$47.89
$46.85
$48.25
$21.21
0.86
685,355
HSP
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Begley, Christopher | Chairman of the Board, Chief Executive Officer | 5,082,430 |
| Werner, Thomas | Chief Financial Officer, Senior Vice President - Finance | 1,591,410 |
| Kearney, Terrence | Chief Operating Officer | 3,415,900 |
Profile
Hospira, Inc. (Hospira), is a specialty pharmaceutical and medication delivery company that develops, manufactures and markets products. Hospira's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems. Hospira's... Full Description
Company Address
Hospira, Inc.
275 North Field Drive
Lake Forest IL 60045
P: +1224.2122000
275 North Field Drive
Lake Forest IL 60045
P: +1224.2122000
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | €35.78 | +0.01 |
| Baxter International Inc. | $54.66 | +0.33 |
| Novartis AG | CHF55.15 | +1.20 |
| HSP | Industry | |
|---|---|---|
| P/E(TTM) | 18.41 | 3.76 |
| P/S(TTM) | 2.03 | 0.51 |
| ROI(TTM) | 9.65 | 2.54 |
| ROE(TTM) | 18.97 | 4.01 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | 0.72 |
| EPS Est. (Current Year) | 2.91 |
| Total Revenue | $1,007.50M |
| Net Income | $116.20M |
| EPS | $0.71 |
